II
119th CONGRESS
2d Session
S. 5237
IN THE SENATE OF THE UNITED STATES
August 4, 2026
Ms. Hassan (for herself and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes.
Short title
This Act may be cited as the Stop Superbugs Act
.
Funding for antibiotic resistance clinical research
In general
The Director of the National Institute of Allergy and Infectious Diseases shall award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, which shall include focuses on—
supporting rapid recruitment of clinical trial participants;
conducting clinical trial recruitment outreach in community settings;
supporting the pairing of diagnostic and pharmaceutical innovations during clinical trials; and
developing patient-reported outcomes in clinical studies.
Authorization of appropriations
There is authorized to be appropriated to the Director of the National Institute of Allergy and Infectious Diseases such sums as may be necessary to carry out subsection (a).